Key p-Hydroxycinnamic Acid Market Players:
- BASF SE
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck KGaA
- Cayman Chemical Company
- Tokyo Chemical Industry Co., Ltd. (TCI)
- Evonik Industries AG
- Sigma-Aldrich (part of Merck Group)
- Santa Cruz Biotechnology
- Abcam plc
- Alfa Aesar (Thermo Fisher Scientific)
- Combi-Blocks Inc.
- Carbosynth Ltd (now part of Biosynth)
- Toronto Research Chemicals
- Matrix Scientific
- Haihang Industry Co., Ltd.
- Wako Pure Chemical Industries (FUJIFILM)
The global p-hydroxycinnamic acid market is moderately fragmented, and many leading players in this opportunity-rich market are using strategic R&D focus-related investments and partnerships for product portfolio expansion. Many of these firms and others are utilizing modern approaches like green synthesis, expanding capacity, and/or custom contract manufacturing to stay competitive in the marketplace. The Japanese companies are establishing their precision synthesis expertise for electronic devices and biomedical applications. By contrast, firms from North America and firms from Europe are focusing on regulation compliance while building application-specific innovation.
Some of the key players operating in the market are listed below:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
The p-hydroxycinnamic acid market size was USD 118.7 million in 2025.
The global p-hydroxycinnamic acid market size was USD 118.7 million in 2025 and is likely to reach USD 278.5 million by the end of 2035, expanding at a CAGR of 6.5% over the forecast period, i.e., 2026-2035.
BASF SE, Merck KGaA, Cayman Chemical Company, Evonik Industries AG, Sigma-Aldrich (part of Merck Group), Santa Cruz Biotechnology, and Abcam plc are some key players in the market.
The cosmetics and personal care segment is expected to hold a leading share during the forecast period.
Asia Pacific is projected to offer lucrative prospects with a share of 43.2% during the forecast period.
